Skip to content

R&D at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$249M+7.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$62.9M-14.4%
Donaldson Company logo
Donaldson CompanyDCI
$19.2M-10.3%
Revvity logo
RevvityRVTY
$57.89M+8.0%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$336M-1.8%
BioLife Solutions logo
BioLife SolutionsBLFS
$2.65M+84.2%

Other financials

Income statement

See full
Revenue$6.0B+3.7%
Gross profit$3.6B+2.3%
Operating income$1.3B+5.5%
Net income$1.0B+7.9%
EPS (diluted)$1.45+9.8%

Balance sheet

See full
Cash & equivalents$5.7B+186%
Total debt$19.7B+12.0%
Total equity$52.9B+4.1%
Total assets$83.5B+5.6%

Cash flow

See full
Operating cash flow$1.3B+1.8%
CapEx$237.0M-3.3%
Free cash flow$1.1B+2.9%

Valuation

See full
Market cap$138.71B-2.9%
Enterprise value$152.69B-3.6%
P/E37.6×-4.3×
P/S5.6×-0.4×

Profitability

See full
Gross margin58.9%-0.8pp
Operating margin19.2%-1.0pp
Net margin14.9%-0.9pp
FCF margin21.4%+0.8pp

Returns & leverage

See full
Return on equity7.1%-0.1pp
Debt / equity0.4×0.0×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Danaher’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's R&D?
Danaher (DHR) reported R&D of $387M in Q1 2026.
How has Danaher's R&D changed year-over-year?
Danaher's R&D increased by 2.1% year-over-year, from $379M to $387M.
What is the long-term trend for Danaher's R&D?
Over 4 years (2021 to 2025), Danaher's R&D has grown at a 1.6% compound annual growth rate (CAGR), from $1.5B to $1.6B.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.